The AMA’s annual prior authorization survey also cites concerns about patient harm, physician burnout and wasted health resources.

“Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The insurance giant complied by denied violating statutes, rules, or regulations.

CEO says the insurance giant will return to “compelling, normalized margins” in 2025.

At the same time, new research suggests employees would be willing to take a salary reduction in exchange for work-from-home flexibility.

The grocery retailer terminated its agreement with the PBM in 2022, citing ‘unsustainable’ pricing model.

"Those companies that take swift action now will … set themselves and their organizations up for success in the decades ahead," says a new report.

New survey raises alarm as expert money manager weighs in with advice.